<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27341804</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2016</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines.</ArticleTitle><Pagination><StartPage>111</StartPage><MedlinePgn>111</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">111</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-016-0567-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Recurrence of hand, foot and mouth disease (HFMD) pandemics continues to threaten public health. Despite increasing awareness and efforts, effective vaccine and drug treatment have yet to be available. Probiotics have gained recognition in the field of healthcare worldwide, and have been extensively prescribed to babies and young children to relieve gastrointestinal (GI) disturbances and diseases, associated or not with microbial infections. Since the faecal-oral axis represents the major route of HFMD transmission, transient persistence of probiotic bacteria in the GI tract may confer some protection against HFMD and limit transmission among children.</AbstractText><AbstractText Label="METHODS">In this work, the antiviral activity of two commercially available probiotics, namely Lactobacillus reuteri Protectis (L. reuteri Protectis) and Lactobacillus casei Shirota (L. casei Shirota), was assayed against Coxsackieviruses and Enterovirus 71 (EV71), the main agents responsible for HFMD. In vitro infection set-ups using human skeletal muscle and colon cell lines were designed to assess the antiviral effect of the probiotic bacteria during entry and post-entry steps of the infection cycle.</AbstractText><AbstractText Label="RESULTS">Our findings indicate that L. reuteri Protectis displays a significant dose-dependent antiviral activity against Coxsackievirus type A (CA) strain 6 (CA6), CA16 and EV71, but not against Coxsackievirus type B strain 2. Our data support that the antiviral effect is likely achieved through direct physical interaction between bacteria and virus particles, which impairs virus entry into its mammalian host cell. In contrast, no significant antiviral effect was observed with L. casei Shirota.</AbstractText><AbstractText Label="CONCLUSIONS">Should the antiviral activity of L. reuteri Protectis observed in vitro be translated in vivo, such probiotics-based therapeutic approach may have the potential to address the urgent need for a safe and effective means to protect against HFMD and limit its transmission among children.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ang</LastName><ForeName>Lei Yin Emily</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Centre for Life Sciences, 28 Medical Drive, #03-05, Singapore, 117456, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Too</LastName><ForeName>Horng Khit Issac</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Centre for Life Sciences, 28 Medical Drive, #03-05, Singapore, 117456, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eng Lee</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National University Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical &amp; Life Sciences, Singapore Polytechnic, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Tak-Kwong Vincent</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Centre for Life Sciences, 28 Medical Drive, #03-05, Singapore, 117456, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shek</LastName><ForeName>Lynette Pei-Chi</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National University Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tham</LastName><ForeName>Elizabeth Huiwen</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, National University Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Centre for Life Sciences, 28 Medical Drive, #03-05, Singapore, 117456, Singapore. micas@nus.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore. micas@nus.edu.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Virol J. 2016 Nov 17;13(1):186. doi: 10.1186/s12985-016-0633-0</RefSource><PMID Version="1">27855715</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018938" MajorTopicYN="N">Caco-2 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052200" MajorTopicYN="N">Limosilactobacillus reuteri</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="N">Probiotics</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Foot and mouth disease</Keyword><Keyword MajorTopicYN="N">Hand</Keyword><Keyword MajorTopicYN="N">Lactobacillus reuteri</Keyword><Keyword MajorTopicYN="N">Probiotics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>6</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27341804</ArticleId><ArticleId IdType="pmc">PMC4920999</ArticleId><ArticleId IdType="doi">10.1186/s12985-016-0567-6</ArticleId><ArticleId IdType="pii">10.1186/s12985-016-0567-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bruu AL: Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. A Practical Guide to Clinical Virology, Second Edition 2003;44-45. doi:10.1002/0470857285.ch6</Citation></Reference><Reference><Citation>Hirata O, Ishikawa N, Mizoguchi Y, Nakamura K, Kobayashi M. A case of neonatal coxsackie B2 meningo-encephalitis in which serial magnetic resonance imaging findings reveal the development of lesions. Neuropediatrics. 2011;42:156&#x2013;8. doi: 10.1055/s-0031-1285876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1285876</ArticleId><ArticleId IdType="pubmed">21877311</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC. Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine. Expert Rev Anti Infect Ther. 2014;12:447&#x2013;56. doi: 10.1586/14787210.2014.895666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2014.895666</ArticleId><ArticleId IdType="pubmed">24579906</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H-I, Weng K-F, Shih S-R. Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol. 2012;7:467&#x2013;79. doi: 10.2217/fmb.12.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.12.22</ArticleId><ArticleId IdType="pubmed">22439724</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, Liang Z. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother. 2014;10:360&#x2013;7. doi: 10.4161/hv.27087.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, Zheng X, Wei R, Zhang N, Zhu K, Xu B, Yang CH, Yang CF, Deng C, Pu D, et al. The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010. PLoS Negl Trop Dis. 2013;7 doi: 10.1371/journal.pntd.0002599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002599</ArticleId><ArticleId IdType="pmc">PMC3868519</ArticleId><ArticleId IdType="pubmed">24367714</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;90. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y, et al. Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect Dis. 2014;14:308&#x2013;18. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A, Henquell C, Archimbaud C, Ughetto S, Antona D, Bailly JL, Peigue-Lafeuille H. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect. 2012;18:E110&#x2013;8. doi: 10.1111/j.1469-0691.2012.03789.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03789.x</ArticleId><ArticleId IdType="pubmed">22404077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Tay J, Phoon MC, Hsu JP, Cutter J, James L, Goh KT, Chow VT. Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008&#x2013;2010. PLoS One. 2015;10:e0127999. doi: 10.1371/journal.pone.0127999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0127999</ArticleId><ArticleId IdType="pmc">PMC4444285</ArticleId><ArticleId IdType="pubmed">26011735</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Pham HV, Hoang CQ, Nguyen TM, Nguyen LT, Phan HC, Phan LT, Vu LN, Minh NNT. Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011. BMC Infect Dis. 2014;14:341. doi: 10.1186/1471-2334-14-341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-341</ArticleId><ArticleId IdType="pmc">PMC4068316</ArticleId><ArticleId IdType="pubmed">24942066</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Jiang L, Liang Z, Mao Q, Su W, Zhang H, Li X, Jin J, Xu L, Zhao D, et al. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice. Hum Vaccin Immunother. 2014;10:2885&#x2013;95. doi: 10.4161/hv.29823.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.29823</ArticleId><ArticleId IdType="pmc">PMC5443096</ArticleId><ArticleId IdType="pubmed">25483672</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Chow YH, Chong P, Klein M. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine. 2014;32:6177&#x2013;82. doi: 10.1016/j.vaccine.2014.08.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.08.064</ArticleId><ArticleId IdType="pubmed">25218294</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JX, Mao QY, Liang ZL, Ji H, Zhu FC. Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials. Expert Rev Vaccines. 2014;13:609&#x2013;18. doi: 10.1586/14760584.2014.897617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2014.897617</ArticleId><ArticleId IdType="pubmed">24621093</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou AH, Liu CC, Chang JY, Jiang R, Hsieh YC, Tsao A, Wu CL, Huang JL, Fung CP, Hsieh SM, et al. Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS One. 2013;8:e79783. doi: 10.1371/journal.pone.0079783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079783</ArticleId><ArticleId IdType="pmc">PMC3836818</ArticleId><ArticleId IdType="pubmed">24278177</ArticleId></ArticleIdList></Reference><Reference><Citation>Group JFWW . Guidelines for the evaluation of probiotics in food. London: World Health Organization. Canada: Food and Agriculture Organization; 2002.</Citation></Reference><Reference><Citation>Reid G, Sanders M, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer TR. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol. 2003;37:105&#x2013;18. doi: 10.1097/00004836-200308000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004836-200308000-00004</ArticleId><ArticleId IdType="pubmed">12869879</ArticleId></ArticleIdList></Reference><Reference><Citation>Mach T. Clinical usefulness of probiotics. J Physiol Pharmacol. 2006;57:23&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">17242485</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan F, Polk DB. Probiotics as functional food in the treatment of diarrhea. Curr Opin Clin Nutr Metab Care. 2006;9:717&#x2013;21. doi: 10.1097/01.mco.0000247477.02650.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mco.0000247477.02650.51</ArticleId><ArticleId IdType="pubmed">17053425</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid G. Probiotic Lactobacilli for urogenital health in women. J Clin Gastroenterol. 2008;42:S234&#x2013;6. doi: 10.1097/MCG.0b013e31817f1298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0b013e31817f1298</ArticleId><ArticleId IdType="pubmed">18685506</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderhoof JA. Probiotics in allergy management. J Pediatr Gastroenterol Nutr. 2008;47:S38&#x2013;40. doi: 10.1097/01.mpg.0000338810.74933.c1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mpg.0000338810.74933.c1</ArticleId><ArticleId IdType="pubmed">18931598</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid G, Jass J, Sebulsky MT, McCormick JK. Potential Uses of Probiotics in Clinical Practice. Clin Microbiol Rev. 2003;16:658&#x2013;72. doi: 10.1128/CMR.16.4.658-672.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.16.4.658-672.2003</ArticleId><ArticleId IdType="pmc">PMC207122</ArticleId><ArticleId IdType="pubmed">14557292</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas IA, Dobrogosz WJ. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microb Ecol Health Dis. 2000;12:247&#x2013;85.</Citation></Reference><Reference><Citation>Hatakka K, Savilahti E, P&#xf6;nk&#xe4; A, Meurman JH, Poussa T, N&#xe4;se L, Saxelin M, Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 2001;322:1327. doi: 10.1136/bmj.322.7298.1327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.322.7298.1327</ArticleId><ArticleId IdType="pmc">PMC32161</ArticleId><ArticleId IdType="pubmed">11387176</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe4;se L, Hatakka K, Savilahti E, Saxelin M, P&#xf6;nk&#xe4; A, Poussa T, Korpela R, Meurman JH. Effect of long&#x2013;term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001;35:412&#x2013;20. doi: 10.1159/000047484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000047484</ArticleId><ArticleId IdType="pubmed">11799281</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H-J, Song J-H, Park K-S, Baek S-H, Lee E-S, Kwon D-H. Antiviral activity of yogurt against enterovirus 71 in vero cells. Food Sci Biotechnol. 2010;19:289&#x2013;95. doi: 10.1007/s10068-010-0042-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10068-010-0042-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanska M, Szajewska H. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr. 2014;173:1327&#x2013;37. doi: 10.1007/s00431-014-2328-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-014-2328-0</ArticleId><ArticleId IdType="pmc">PMC4165878</ArticleId><ArticleId IdType="pubmed">24819885</ArticleId></ArticleIdList></Reference><Reference><Citation>Savino F, Ceratto S, Poggi E, Cartosio ME, Cordero di Montezemolo L, Giannattasio A. Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938. Benef Microbes. 2015;6:245&#x2013;51. doi: 10.3920/BM2014.0090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2014.0090</ArticleId><ArticleId IdType="pubmed">25488262</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinleyici EC, Group PS, Vandenplas Y. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatr. 2014;103:e300&#x2013;5. doi: 10.1111/apa.12515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.12515</ArticleId><ArticleId IdType="pubmed">24579935</ArticleId></ArticleIdList></Reference><Reference><Citation>Savino F, Fornasero S, Ceratto S, De Marco A, Mandras N, Roana J, Tullio V, Amisano G. Probiotics and gut health in infants: A preliminary case-control observational study about early treatment with Lactobacillus reuteri DSM 17938. Clin Chim Acta. 2015;451:82&#x2013;7. doi: 10.1016/j.cca.2015.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2015.02.027</ArticleId><ArticleId IdType="pubmed">25704298</ArticleId></ArticleIdList></Reference><Reference><Citation>Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HF. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation-The aim of the present study was to investigate the effect of a. Can J Gastroenterol. 2003;17:655&#x2013;60. doi: 10.1155/2003/654907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2003/654907</ArticleId><ArticleId IdType="pubmed">14631461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shida K, Sato T, Iizuka R, Hoshi R, Watanabe O, Igarashi T, Miyazaki K, Nanno M, Ishikawa F. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. Eur J Nutr. 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5290054</ArticleId><ArticleId IdType="pubmed">26419583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I, Ishiguro S, Miyaoka E, Sobue T, Kakizoe T. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer. 2005;116:762&#x2013;7. doi: 10.1002/ijc.21115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.21115</ArticleId><ArticleId IdType="pubmed">15828052</ArticleId></ArticleIdList></Reference><Reference><Citation>De Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr. 2000;71:405&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">10648252</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan R, Meyer R, Padmanabhan R, Britto J. Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. J Pediatr Gastroenterol Nutr. 2006;42:171&#x2013;3. doi: 10.1097/01.mpg.0000189335.62397.cf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mpg.0000189335.62397.cf</ArticleId><ArticleId IdType="pubmed">16456410</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosander A, Connolly E, Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol. 2008;74:6032&#x2013;40. doi: 10.1128/AEM.00991-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.00991-08</ArticleId><ArticleId IdType="pmc">PMC2565949</ArticleId><ArticleId IdType="pubmed">18689509</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf6;yry T, Hyypi&#xe4; T, Horsnell C, Kinnunen L, Hovi T, Stanway G. Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology. 1994;202:982&#x2013;7. doi: 10.1006/viro.1994.1423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1423</ArticleId><ArticleId IdType="pubmed">8030260</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Poh CL, Chow VTK. Complete Sequence Analyses of Enterovirus 71 Strains from Fatal and Non&#x2010;Fatal Cases of the Hand, Foot and Mouth Disease Outbreak in Singapore (2000) Microbiol Immunol. 2002;46:801&#x2013;8. doi: 10.1111/j.1348-0421.2002.tb02767.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2002.tb02767.x</ArticleId><ArticleId IdType="pubmed">12516778</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Kassaa I, Hober D, Hamze M, Chihib NE, Drider D. Antiviral potential of lactic acid bacteria and their bacteriocins. Probiotics Antimicrob Proteins. 2014;6:177&#x2013;85. doi: 10.1007/s12602-014-9162-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12602-014-9162-6</ArticleId><ArticleId IdType="pubmed">24880436</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Wong KT. Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses. Brain Pathol. 2015;25:614&#x2013;24. doi: 10.1111/bpa.12279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12279</ArticleId><ArticleId IdType="pmc">PMC8029433</ArticleId><ArticleId IdType="pubmed">26276025</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CS, Yao YC, Lin SC, Lee YP, Wang YF, Wang JR, Liu CC, Lei HY, Yu CK. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol. 2007;81:8996&#x2013;9003. doi: 10.1128/JVI.00236-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00236-07</ArticleId><ArticleId IdType="pmc">PMC1951457</ArticleId><ArticleId IdType="pubmed">17567704</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollenweider S, Grassi G, K&#xf6;nig I, Puhan Z. Purification and structural characterization of 3-hydroxypropionaldehyde and its derivatives. J Agric Food Chem. 2003;51:3287&#x2013;93. doi: 10.1021/jf021086d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf021086d</ArticleId><ArticleId IdType="pubmed">12744656</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleusix V, Lacroix C, Vollenweider S, Duboux M, Le Blay G. Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiol. 2007;7:101. doi: 10.1186/1471-2180-7-101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-7-101</ArticleId><ArticleId IdType="pmc">PMC2222629</ArticleId><ArticleId IdType="pubmed">17997816</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastromarino P, Cacciotti F, Masci A, Mosca L. Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components. Anaerobe. 2011;17:334&#x2013;6. doi: 10.1016/j.anaerobe.2011.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anaerobe.2011.04.022</ArticleId><ArticleId IdType="pubmed">21621625</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin KW, Huimin Y, Alonso S. Enterovirus 71: pathogenesis, control and models of disease. Futur Virol. 2012;7:989&#x2013;1004. doi: 10.2217/fvl.12.89.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl.12.89</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JK, Chow VT, Alonso S. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol. 2012;86:2121&#x2013;31. doi: 10.1128/JVI.06103-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto I, HAGIWARA A. Pathogenicity Of A Poliomyelitis&#x2010;Like Disease In Monkeys Infected Orally With Enterovirus 71: A Model For Human Infection. Neuropathol Appl Neurobiol. 1982;8:149&#x2013;56. doi: 10.1111/j.1365-2990.1982.tb00269.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1982.tb00269.x</ArticleId><ArticleId IdType="pubmed">7048123</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>